First Trust Capital Management L.P. - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 6 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
First Trust Capital Management L.P. ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$2,090,000
+24.3%
208,598
+22.8%
0.10%
-16.1%
Q2 2022$1,682,000
+2.1%
169,858
+1.4%
0.12%
-33.3%
Q1 2022$1,648,000
+0.8%
167,5250.0%0.18%
-38.3%
Q4 2021$1,635,000
-0.2%
167,5250.0%0.29%
+15.7%
Q3 2021$1,638,000
-0.6%
167,525
+0.1%
0.25%
+0.8%
Q2 2021$1,648,000167,4250.25%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q4 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,008,0001.47%
683 Capital Management, LLC 600,000$6,012,0000.46%
CVI Holdings, LLC 367,552$3,687,0000.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,004,0000.26%
SkyView Investment Advisors, LLC 71,773$719,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,999$10,020,0000.20%
GLAZER CAPITAL, LLC 1,022,411$10,245,0000.19%
METEORA CAPITAL, LLC 56,076$562,0000.14%
Cowen Investment Management LLC 50,000$501,0000.11%
First Trust Capital Management L.P. 208,598$2,090,0000.10%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders